Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents of Ping An Biomedical Co., Ltd. from 30 Sep 2022 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD and CNY
Description
Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.
Summary
Ping An Biomedical Co., Ltd. quarterly Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents in USD history and change rate from 30 Sep 2022 to 30 Sep 2025.
  • Ping An Biomedical Co., Ltd. Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents for the quarter ending 30 Sep 2025 was $5,154,697, a 27928% increase year-over-year.
Ping An Biomedical Co., Ltd. quarterly Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents in CNY history and change rate from 30 Sep 2022 to 30 Sep 2025.
  • Ping An Biomedical Co., Ltd. Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents for the quarter ending 30 Sep 2025 was ¥36,696,290, a 27929% increase year-over-year.
Source SEC data
View on sec.gov
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Quarterly (USD)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, YoY Quarterly Change (%)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Quarterly (CNY)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, YoY Quarterly Change (%)

Ping An Biomedical Co., Ltd. Quarterly Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $5,154,697 +$5,136,306 +27928% 30 Sep 2025 20-F 30 Jan 2026 2025 FY
Q1 2025 $15,110 31 Mar 2025 6-K 29 Sep 2025 2025 Q2
Q3 2024 $18,391 30 Sep 2024 20-F 30 Jan 2026 2025 FY

Ping An Biomedical Co., Ltd. Quarterly Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents (CNY)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 ¥36,696,290 +¥36,565,367 +27929% 30 Sep 2025 20-F 30 Jan 2026 2025 FY
Q1 2025 ¥109,652 -¥859,969 -89% 31 Mar 2025 6-K 29 Sep 2025 2025 Q2
Q3 2024 ¥130,923 -¥460,951 -78% 30 Sep 2024 20-F 30 Jan 2026 2025 FY
Q1 2024 ¥969,621 31 Mar 2024 6-K 29 Sep 2025 2025 Q2
Q3 2023 ¥591,874 -¥574,664 -49% 30 Sep 2023 20-F 30 Jan 2026 2025 FY
Q3 2022 ¥1,166,538 30 Sep 2022 20-F 30 Jan 2026 2025 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.